Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials

Lancet

Volumn 350, Issue 9089, 1997, Pages 1417-1424

  Connolly, Stuart J ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIVER TOXICITY; LUNG TOXICITY; META ANALYSIS; MORTALITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SUDDEN DEATH;

EID: 0031583760     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)05281-1     Document Type: Article

References (27)

1. LeFeuvre CA, Connolly SJ, Cairns JA, Gent M, Roberts RS. Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically-defined stable population. AmJ Cardiol 1996; 78: 1345-49.
2. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarhythmic drug therapy in acute myocardial infarction: an overview of results of randomised controlled clinical trials. JAMA 1993; 270: 1589-95.
3. The Cardiac Arrhythmia Supression Trial (CAST) Investigators. Effect of encainide and flecainide on mortality in infarction. N Engl J Med 1989; 321: 406-12.
4. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of antiarrhythmiac agent moriczine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-33.
5. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12.
6. Podrid PJ. Amiodarone: re-evaluation of an old drug. Ann Intern Med 1995; 122: 689-700.
7. Cairns JA, Connolly SJ, Roberts RS, Gent M, and the CAMIAT Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-82.
8. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, EMIAT Investigators. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-74.
9. Elizari M, Martinez JM, Belzitic C, et al. Mortality following early administration of amiodarone in acute myocardial infarction: results of the GEMICA trial. Circulation 1996; 94 (suppl 1): 90.
10. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. JACC 1992; 20: 1056-62.
11. Navarro-Lopez F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A for the SSSD Investigators. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. AmJ Cardiol 1993; 72: 1243-48.
12. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). JACC 1990; 16: 1711-18.
13. Hockings BEF, George T, Mahrous F, Taylor RR, Hajar HA. Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. Am J Cardiol 1987; 60: 967-70.
14. Cairns JA, Connolly SJ, Gent M, Roberts R. Post myocardial infarction mortality in patients with ventricular premature depolarizations. Circulation 1991; 84: 550-57.
15. Singh SN, Fletcher RD, Fisher SG, et al for the Survival Trial in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
16. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-98.
17. Garguichevich JJ, Ramos JL, Gambarte A, et al, for the Argentine Pilot Study of Sudden Death and Amiodarone Investigators. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine pilot study of sudden death and amiodarone (EPAMSA). Am Heart J 1995; 130: 494-500.
18. Nicklas JM, McKenna WJ, Stewart RA, et al. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991; 122: 1016-21.
19. Hamer AWF, Arkles B, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. JACC 1989; 14: 1768-74.
20. Gottlieb SS. Dead is dead - artificial definitions are no substitute. Lancet 1997; 349: 662-63.
21. Whitehead A, Whitehead J. A general parametric approach to metaanalysis of randomized controlled trials. Stat Med 1991; 10: 1665-77.
22. Early Breast Cancer Trialists Collaboration Group. Treatment of early breast cancer, vol 1: worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990: 12-18.
23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
24. DerSimonian R, Laird N. Meta analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-88.
25. DeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analysis and subsequent large randomized controlled trials. N Engl J Med 1997; 337: 536-42.
26. Peto R, Collins R, Gray R. Large-scale randomized evidence: large simple trials and overviews of trials. J Clin Epidemiol 1995; 48: 23-40.
27. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995; 142: 371-82.